Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Something seems to be going awry with GlaxoSmithKline's game plan for its respiratory franchise ... expected to the company's cardiovascular drug Lovaza (omega-3-acid ethyl esters) from generic ...

New research finds that SGLT-2is and GLP-1RAs are linked to lower risk of COPD exacerbations in patients with Type 2 diabetes ...